Hôpital Français de Hanoï for their dedication during the<unk>  crisis As<unk>  is a viral disease, antibiotics do not have direct effect but may be used against bacterial secondary infection. Treatment of<unk>  is mainly supportive with antipyretics, supplemental oxygen and mechanical ventilation as needed. While ribavirin is commonly used to treat<unk> , there seems to have little to no effect on<unk> -CoV, and no impact on patient's outcomes. There is currently no proven antiviral therapy. Tested substances, include ribavirin, lopinavir, ritonavir, type I interferon, that have thus far shown no conclusive contribution to the disease's course. Administration of corticosteroids, is recommended by the British Thoracic Society/British Infection Society/Health Protection Agency in patients with severe disease and O2 saturation of <90%. People with<unk> -CoV must be isolated, preferably in negative-pressure rooms, with complete barrier nursing precautions taken for any necessary contact with these patients, to limit the chances of medical personnel becoming infected. In certain cases, natural ventilation by opening doors and windows is documented to help decreasing indoor concentration of virus particles. Some of the more serious damage caused by<unk>  may be due to the body's own immune system reacting in what is known as cytokine storm. Vaccine Vaccines can help immune system to create enough antibodies and also it can help to decrease a risk of side effects like arm pain, fever, headache etc. According to research papers published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat<unk>  was a priority for governments and public health agencies around the world. In early 2004, an early clinical trial on volunteers was planned. A major researcher's 2016 request, however, demonstrated that no field-ready<unk>  vaccine had been completed because likely market-driven priorities had ended funding.
SARS
E-med
SCoRS
ICECI
SIRS
DICOM
ICES
PAMI